V

Varian

Tech-enabled radiation oncology hardware and software

Regional Sales Director - Lab Diagnostics, Rocky Mountains

Full-TimeUpdated on 10/23/2026
$159.2k - $218.9k+ Commission
Expert
Bachelor's
Remote in USA
RemoteRemote, field-based role; candidate must reside and have experience in the assigned region.
Sales & Account ManagementField Sales
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • A track record of success leading sales teams or sales team members in Laboratory Diagnostics is required; the candidate must reside in and have experience in the region, with knowledge of the respective Integrated Delivery Networks.
  • Effective communication and interpersonal skills, including the ability to work cross-functionally.
  • Inspirational leadership, the ability to motivate others, accountability, drive for results, organizational agility, and the ability to establish trust and rapport quickly and build an effective team.
  • Business acumen in financial matters, market positioning, the healthcare industry, and customer relations.
  • Experience in training and development, with a focus on coaching and mentoring.
  • A proven record in a solution-selling environment and large account development, with 7 to 10+ years of experience in a complex sales environment such as capital equipment, medical, or devices.
  • Strategic decision-making focused on impact and speed, critical thinking, advanced sales, problem-solving, and objection-handling skills.
  • A valid driver's license in the state of residence; applicants may not have prior or pending DUI/DWI convictions or charges or other serious moving violations unless prohibited by state or local law.
  • Ability to work with controlled technology in accordance with United States export control law.
Responsibilities
  • Drive commitment and accountability of the core laboratory sales team to achieve and exceed sales goals, grow revenue at assigned integrated delivery networks, hospital laboratories, regional reference labs, and physician office labs.
  • Drive overall revenue growth for central laboratory product lines, including chemistry, immunoassay, coagulation, hematology, plasma protein, allergy, automation, and information technology.
  • Continuously develop assigned sales teams and ensure direct sales staff are appropriately trained and competent in customer management, product and solution positioning, and applicable sales processes and tools; coach, promote, and manage adherence to commercial best practices.
  • Hire and develop a sales team of 6–8 direct reports; set mutual expectations for biannual review, provide frequent feedback, discuss individual development opportunities annually, and manage performance-improvement cases as needed.
  • Determine priorities for pursuing must-win deals, develop short-term (3–6 month) and long-term (2–3 year) strategic sales plans, and ensure their implementation.
  • Coach the team on account strategy and own the commercial outcome of new instrument opportunities, including reagent and consumable revenue growth, total cost of ownership, and instrument placements.
  • Maintain direct customer relationships, understand regional market conditions, and lead the direct sales team in understanding and addressing customer needs and delivering the company's value proposition.
  • Own the execution and output of sales operational activities and metrics, including sales-funnel management, customer relationship management tool rigor, sales processes, critical-account coverage, account financial health, contract management, and compliance.
  • Own capital and reagent forecasting in the region and ensure forecast quality and accuracy across product lines, as well as top- and bottom-line financial outcomes for each deal.
  • Own commercial outcomes for existing customers across reagent and consumable revenue growth, menu expansion, and contract compliance for assigned accounts.
  • Conduct regular reviews with the Area Vice President and Field Product Manager, driving organization-wide commercial strategy in the region.
  • Coordinate with the Strategic Corporate Accounts organization, internal sales teams, distribution partners, technical and service organizations to develop strategy and implement tactics that achieve sales goals.
  • Lead collaborative work with teams within and outside the region to ensure excellent customer solutions and experiences, including Health Systems Executives, Service, Technical Applications, and Strategic Corporate Accounts, measured through regular customer feedback.
  • Leverage Healthcare Consulting Services and Informatics Sales Specialists during the sales cycle.
  • Work jointly with Service, Technical Applications, Business Operations, Finance, Marketing, Human Resources, and other internal teams to ensure positive customer solutions and experiences.
  • Develop and manage a collaborative environment within the team and with partners, maintaining accountability for a solution-based approach that balances customer needs with company financial goals.
  • Lead the assigned sales region to achieve and exceed sales goals across Laboratory Solutions products and be accountable for the sales team's regional financial performance.
  • Manage and resolve business problems, particularly in dynamic environments.
  • Exercise sound judgment and decision-making aligned with the company's commercial strategy.
Desired Qualifications
  • Experience developing account-level deal strategy using Miller Heiman and organizing a team to execute the plan of action.
  • Direct management of a sales team within the in vitro diagnostics market.
  • Ability to communicate effectively with the Area Vice President to keep them informed about business priorities and results, and to convey the Area Vice President's direction to the regional sales force through email, Teams, and in-person communication with customers, internal teams, and leadership.
  • Knowledge of product lines, markets, and competitors.
  • Bachelor of Science or Bachelor of Arts in a related discipline, an advanced degree where required, or an equivalent combination of education and experience.
  • Experience managing a direct sales team.

About the company

Varian, part of Siemens Healthineers, focuses on oncology by providing integrated radiation oncology solutions that combine software, hardware, patient data, and care teams. Its offerings include treatment-planning software, radiation therapy machines, and data-management systems that work together to enable precise cancer treatments. The company differentiates itself through an integrated platform approach and services like Oncology-as-a-Service (OaaS), which lets healthcare providers adopt advanced radiation oncology with ongoing service support rather than large upfront investments. Varian serves healthcare providers such as hospitals and cancer centers, helping them deliver coordinated care and improve patient outcomes. Its goal is to reduce the fear of cancer by using data and technology to support clinicians in delivering effective treatments.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Palo Alto, California

Founded

1948

Get referred to Varian

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ARPA-H awarded Varian up to $60 million in April 2026 for FLASH-RT.
  • FDA cleared TrueBeam for osteoarthritis in March 2026, opening a non-cancer market.
  • Telix collaboration and 2026 AI approvals expand Varian's clinical and software pipeline.

What critics are saying

  • RaySearch enabled online adaptive TrueBeam workflows in Belgium in May 2026, eroding software differentiation.
  • Elekta still attacks Varian's lead in adaptive radiotherapy and premium MR-guided care.
  • If FLASH and non-oncology bets fail by 2028, Varian becomes a commoditized linear-accelerator vendor.

What makes Varian unique

  • Siemens Healthineers gives Varian imaging, radiotherapy, and capital-sales integration globally.
  • Varian's 2026 CE-marked Eclipse AI contouring deepens workflow lock-in across planning.
  • TrueBeam, Halcyon, and Ethos create an installed-base moat hospitals rarely replace.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours
  • Remote Work Options
  • Paid Vacation
  • Paid Holidays
  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Wellness Program
  • 401(k) Retirement Plan

Growth & Insights and Company News

6 month growth

2%

1 year growth

3%

2 year growth

3%
Varex Imaging Corporation
Sep 14th, 2026
About Us | Varex Imaging Corporation

We strive to help customers become world-class system suppliers by strengthening their competitiveness and enabling them to bring products to market faster

MEDQOR
Apr 30th, 2026
Siemens Healthineers secures $83M to develop photon Flash radiotherapy for cancer treatment

Siemens Healthineers has received up to $60 million from the US Advanced Research Projects Agency for Health to develop photon Flash radiotherapy, with the company contributing an additional $23 million, totalling $83 million over five years. Flash photon therapy delivers radiotherapy more than 100 times faster than current technologies, aiming to reduce side effects and improve healthy tissue sparing. Unlike proton and electron beam platforms, which face scalability challenges, photon beams are the standard of care for over 50% of cancer patients. The project will build on existing C-arm linear accelerators to enable broader clinical access. Siemens Healthineers aims to transition ultra-high dose rate radiotherapy from experimental treatment into global standard of care within the five-year timeframe.

Business Wire
Mar 19th, 2026
Varian TrueBeam gets FDA clearance for low-dose radiotherapy to treat osteoarthritis

Siemens Healthineers has received FDA 510(k) clearance for its Varian TrueBeam radiotherapy systems to treat medically refractory osteoarthritis in adults using low-dose radiation therapy. This marks the first expansion of Varian's radiotherapy platform beyond cancer care into chronic musculoskeletal conditions. Osteoarthritis affects over 33 million adults in the US and approximately 600 million globally. The clearance covers TrueBeam, TrueBeam STx, VitalBeam and Edge systems, offering patients with persistent pain a non-invasive outpatient treatment option that targets inflammation, reduces pain and improves joint function. The approval builds on Varian's previous regulatory clearances for non-oncological indications, including radiosurgery treatment for medically refractory essential tremor. The TrueBeam platform combines high-resolution imaging with precise dose control whilst maintaining streamlined clinical workflows.

AuntMinnieEurope.com
Dec 10th, 2025
Telix and Varian enter research collaboration

Telix and Varian enter research collaboration. Telix Pharmaceuticals and Siemens Healthineers' company Varian have agreed to develop novel clinical applications that combine Telix's theranostics products and Varian's external beam radiation therapy (EBRT) technology. The first area of focus will be in identifying opportunities to use Telix's prostate cancer PET imaging agents in selecting patients for EBRT, developing personalized treatment plans (particularly in the context of Varian's Ethos adaptive radiotherapy system), and monitoring responses to treatment, Telix said. The agreement supports both company-sponsored and investigator-led clinical studies. Varian is a key player in EBRT and working with the company will allow Telix to explore how theranostics can be used more effectively by radiation oncologists to enhance patient selection and deliver targeted treatment, Telix noted. I agree to receive marketing related digital communications about products, services, events and offers that may be relevant to my given user preferences and behavior. I agree to share my information with the sponsor. I have read and agree to the privacy policy & terms of service and wish to opt-in.

AuntMinnie.com
Mar 28th, 2025
Varian, Embolx sign image-guided microcatheter agreement

Siemens Healthineers company Varian has entered into a sales and marketing agreement with Embolx for its Sniper Balloon Occlusion Microcatheter.